Showing 2601-2610 of 9902 results for "".
The HRQoL Impact of Psoriasis: Perspectives for Value-Based Reimbursement
https://practicaldermatology.com/topics/psoriasis/the-hrqol-impact-of-psoriasis-perspectives-for-value-based-reimbursement/20932/Understanding the psychological/social burden of psoriasis on patients is critical as new therapeutics position themselves for reimbursement in a crowded and increasingly undifferentiated field.A Global Approach to Perioral Rejuvenation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-global-approach-to-perioral-rejuvenation/18615/Joel L.Cohen, MD, Director of AboutSkin Dermatology and DermSurgery in Englewood and Lone Tree, CO, discusses the new thinking about perioral rejuvenation at the Cosmetic Surgery Forum 2015 in Las Vegas. He shares techniques for a combination approach for the best, most natural results for enhancingExpanding Indications for Neuromodulators and Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/expanding-indications-for-neuromodulators-and-fillers-/18626/Emerging science of neuromodulators and fillers are expanding the role of these agents in dermatology practice, according to Dee Anna Glaser, MD. An intriguing area of research, she said, is the use of neuromodulators in the treatment of scars, as well as at the time of surgery for scar prevention.Building a Compelling Brand for Your Healthcare Practice
https://practicaldermatology.com/topics/practice-management/building-a-compelling-brand-for-your-healthcare-practice--ovugeroo/18887/It's all about the brand. Know how to successfully develop and convey your brand to visitors online—current and potential patients both. An Ekwa Educational Video.Increasing Patient Compliance with the Right Vehicles
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/increasing-patient-compliance-with-the-right-vehicles/18877/Peter Lio, MD and Elaine Siegfried, MD talk about their vehicles of choice to enhance patient adherence to treatment, especially when treating scalp psoriasis. They also discuss how packaging innovations have led to vehicle innovations.Antiaging Medicine Meets Aesthetics
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/antiaging-medicine-meets-aesthetics/18883/Antiaging medicine supports overall patient health and can be a complement to aesthetic medicine. Greg Buford, MD talks about anti aging medicine and its role in his practice.Make a Profound Impact
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/make-a-profound-impact/18886/Macrene Alexiades, MD, Ph.D, shares her experience with the Profound system, a micro-needling RF device, with real-time temperature feedback mechanism that improves mandibular and submandibular contouring. The device works by stimulating collagen, elastin and hyaluronic acid resulting in a youthfulJoin Us for NewDerm LIVE: Welcome from the Chairs
https://practicaldermatology.com/topics/practice-management/join-us-for-newderm-live-welcome-from-the-chairs/18920/Join us September 18-20, 2015 at the W Hollywood, CA for NewDerm Live, the meeting that's focused on you—so you can focus on your future. Program chairs Sabrina Fabi, MD, Peter Lio, MD, and Kavita Mariwalla, MD, talk about the goals of the meeting and explain why they decided to be part of this exciGuys Don't Be Like Paul
https://practicaldermatology.com/topics/skin-cancer-photoprotection/guys-don-t-be-like-paul/18923/Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network project. The first PSA and video focuses specifically on men and features Dr. Keaney. Data from the Skin Cancer Foundation cited by ASDS show that only 30 percent of American men areDerms Fight MOC; Cipher Buys Innocutis
https://practicaldermatology.com/topics/practice-management/dermwiretv-derms-fight-moc-cipher-buys-innocutis/18930/The AAD asks the American Board of Dermatology for changes to Maintenance of Certification (MOC) requirements; Jeanine Downie, MD and Heidi Waldorf, MD discuss problems with current and proposed requirements. Galderma presents data to support new investigational adapalene 0.3%/benzoyl peroxide 2.5%